Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women
- 31 May 2012
- journal article
- research article
- Published by Elsevier BV in Contraception
- Vol. 85 (5), 480-488
- https://doi.org/10.1016/j.contraception.2011.10.003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency ContraceptionObstetrics & Gynecology, 2010
- The spectrum of endometrial pathology induced by progesterone receptor modulatorsLaboratory Investigation, 2008
- Progesterone receptor modulators and the endometrium: changes and consequences†Human Reproduction Update, 2007
- Progesterone Receptor Antagonists and the Endometrial Antiproliferative EffectSeminars in Reproductive Medicine, 2005
- Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohortInternational Journal of Cancer, 2004
- In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristoneThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometriumSteroids, 2000
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- Antiprogestins: Mechanism of Action and Contraceptive PotentialAnnual Review of Pharmacology and Toxicology, 1996